Financial reports
Current reports
8-K
Completion of Acquisition or Disposition of Assets
11 Jan 23
8-K
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022
12 Dec 22
8-K
Form of Tender and Support Agreement
21 Nov 22
8-K
Imago BioSciences Reports Third Quarter 2022 Financial
9 Nov 22
8-K
Departure of Directors or Certain Officers
1 Sep 22
8-K
Other Events
18 Aug 22
8-K
Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates
12 Aug 22
8-K
Regulation FD Disclosure
13 Jun 22
8-K
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at EHA 2022
10 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
6 Jun 22
Registration and prospectus
15-12G
Securities registration termination
23 Jan 23
25-NSE
Exchange delisting
11 Jan 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Jan 23
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Jan 23
POS AM
Prospectus update (post-effective amendment)
11 Jan 23
SC 14D9/A
Tender offer solicitation (amended)
11 Jan 23
SC TO-T/A
Third party tender offer statement (amended)
11 Jan 23
SC 14D9/A
Tender offer solicitation (amended)
3 Jan 23
SC TO-T/A
Third party tender offer statement (amended)
21 Dec 22
SC 14D9/A
Tender offer solicitation (amended)
21 Dec 22
Other
EFFECT
Notice of effectiveness
17 Jan 23
EFFECT
Notice of effectiveness
30 Aug 22
CORRESP
Correspondence with SEC
25 Aug 22
UPLOAD
Letter from SEC
19 Aug 22
EFFECT
Notice of effectiveness
16 Jul 21
CERT
Certification of approval for exchange listing
15 Jul 21
CORRESP
Correspondence with SEC
13 Jul 21
CORRESP
Correspondence with SEC
13 Jul 21
CORRESP
Correspondence with SEC
25 Jun 21
UPLOAD
Letter from SEC
26 May 21
Ownership
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 23
SC 13G/A
Farallon Capital Partners, L.P.
1 Feb 23
SC 13G/A
BlackRock Inc.
26 Jan 23
SC 13G/A
BlackRock Inc.
20 Jan 23
SC 13D/A
Clarus Lifesciences III, L.P.
12 Jan 23
4
LAURIE KEATING
11 Jan 23
4
Enoch Kariuki
11 Jan 23
4
Amy E. Tapper
11 Jan 23
4
Hugh Rienhoff JR
11 Jan 23
4
Laura G. Eichorn
11 Jan 23